PCORI Funding Should Favor Areas With No Other Economic Incentives For Research, Former FDA Official Gottlieb Says
Executive Summary
The Patient-Centered Outcomes Research Institute should focus its research agenda on areas where information is needed but is unlikely to be generated by the commercial market because there would be little financial incentive to do so, according to former government official Scott Gottlieb.
You may also be interested in...
PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones
It may not feel like it to exhausted user fee negotiators, but the release of FDA’s draft commitment letter for PDUFA V signals the start of more long campaigns for the agency and pharmaceutical companies.
Equal Access To Data Needed For CER To Be Effective, NPC Exec Says
With the Patient-Centered Outcomes Research Institute beginning the early grant process and other data collection initiatives such as FDA’s Sentinel and Janus programs also underway, National Pharmaceutical Council Chief Science Officer Robert Dubois is recommending changes in policy that will allow equal access for industry and academia to data used in comparative effectiveness studies.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.